Janus Henderson Global Life Sciences Fund Class D
JNGLX
NASDAQ
| Weiss Ratings | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Janus Henderson | |||
| Manager/Tenure (Years) | Andy Acker (17), Daniel Lyons (2) | |||
| Website | http://janushenderson.com | |||
| Fund Information | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Janus Henderson Global Life Sciences Fund Class D | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 31, 1998 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.33% | |||
| Dividend | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.27% | |||
| Asset Allocation | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.36% | |||
| Stock | 98.70% | |||
| U.S. Stock | 81.19% | |||
| Non-U.S. Stock | 17.51% | |||
| Bond | 0.01% | |||
| U.S. Bond | 0.01% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.32% | |||
| Convertible | 0.04% | |||
| Other Net | 0.57% | |||
| Price History | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.00% | |||
| 30-Day Total Return | -1.57% | |||
| 60-Day Total Return | 2.83% | |||
| 90-Day Total Return | -3.01% | |||
| Year to Date Total Return | 4.27% | |||
| 1-Year Total Return | 0.39% | |||
| 2-Year Total Return | 18.04% | |||
| 3-Year Total Return | 24.09% | |||
| 5-Year Total Return | 57.74% | |||
| Price | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $70.79 | |||
| 1-Month Low NAV | $70.79 | |||
| 1-Month High NAV | $73.20 | |||
| 52-Week Low NAV | $67.47 | |||
| 52-Week Low NAV (Date) | Jan 14, 2025 | |||
| 52-Week High NAV | $82.60 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.68 | |||
| Standard Deviation | 14.52 | |||
| Balance Sheet | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 4.95B | |||
| Operating Ratios | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.80% | |||
| Turnover Ratio | 35.00% | |||
| Performance | JNGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 8.18% | |||
| Last Bear Market Total Return | -8.25% | |||
